FindTrial
Sign In

Use of shitivara seed powder to access its efficacy on recurrent urinary tract infections

To evaluate the efficacy of Shitivara seed powder (Celosia argentea L) in the management of Mutrakrichchra wsr to Recurrent urinary tract infection A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044690
Enrollment
70
Registered
2022-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N398- Other specified disorders of urinary system

Interventions

None listed

Sponsors

Institute of medical sciences banars hindu university varanasi uttar pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adult male and female subjects aged 18 to 60 years presenting symptoms of recurrent urinary tract infection with positive urine culture 2 Subjects willing to sign informed consent and follow the study procedure 3 Subjects who has not participated in any similar kind of clinical study in the last one month 4 Patients sensitive to the controlled drug

Exclusion criteria

Exclusion criteria: 1 Complicated UTIs 2 known renal tract anomaly 3 Neurogenic bladder 4 Perform self-catheterization or has an indwelling catheter 5 Patients with incomplete bladder emptying 6 History of interstitial cystitis or painful bladder syndrome 7 Urothelial cancer 8 Pregnancy 9 Genital Herpes 10 Tuberculosis affecting the bladder 11 Diabetes mellitus 12 HIV and HBsAg positive subjects

Design outcomes

Primary

MeasureTime frame
According to Urinary Tract Infection Symptoms Assessment QuestionnaireTimepoint: Day0 4weeks 8weeks—

Secondary

MeasureTime frame
To observe the changes in quality of life in the patientsTimepoint: 60 days—

Countries

India

Contacts

Public ContactDr Rahul sherkhane

Institute Of Medical Sciences Banaras Hindu University

rahulsherkhane@gmail.com8233829723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026